Clinical and Molecular Evolution of an <i>ALK</i>-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors-Reference-Cited by-同舟云学术

Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors

Published:2023-03 Issue:7 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Gene-Olaciregui Nagore¹,Perez-Somarriba Marta²³^ORCID,Santa-María Vicente²^ORCID,Cruz Ofelia²,Gómez-González Soledad⁴^ORCID,Castañeda Alicia⁵,Suñol Mariona⁶,Rovira Carlota⁶^ORCID,Muchart Jordi⁷^ORCID,Hinojosa José⁸^ORCID,La Madrid Andrés Morales²^ORCID,Lavarino Cinzia¹^ORCID

Affiliation:

1. Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain

2. Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain

3. Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom

4. Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain

5. Pediatric Solid Tumor Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain

6. Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain

7. Department of Radiology, Hospital Sant Joan de Déu, Barcelona, Spain

8. Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.22.00547

Reference24 articles.

1. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

2. Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

3. Congenital tumors of the central nervous system: an institutional review of 64 cases with emphasis on tumors with unique histologic and molecular characteristics

4. Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives

5. High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapies